Related Experiment Video

Updated: Sep 27, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

MRK, a mixed lineage kinase-related molecule that plays a role in gamma-radiation-induced cell cycle arrest

Eleanore A Gross1, Marinella G Callow, Linda Waldbaum

  • 1Picower Institute for Medical Research, Manhasset, New York 11030, USA.

The Journal of Biological Chemistry
|February 12, 2002
PubMed

Insights

A newly identified human MAP kinase kinase kinase (MAPKKK), MRK, plays a crucial role in cell cycle regulation and DNA damage response. MRK activity is essential for gamma-radiation-induced cell cycle arrest, highlighting its importance in DNA repair pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Mitogen-activated protein (MAP) kinase pathways are conserved signaling modules regulating diverse cellular functions.
  • Identifying novel components of these pathways is crucial for understanding cellular responses to stimuli like DNA damage.

Purpose of the Study:

  • To identify and characterize a novel human MAP kinase kinase kinase (MAPKKK) involved in cellular signaling.
  • To elucidate the role of this kinase in response to gamma-radiation and its impact on cell cycle regulation.

Main Methods:

  • Functional complementation screen in yeast to identify MAPKKK.
  • Gene structure analysis and identification of splice variants (MRK-alpha and MRK-beta).
  • In vitro kinase assays, cell transfections, and analysis of endogenous proteins in Madin-Darby canine kidney cells.

Main Results:

  • Identified MRK (MLK-related kinase), a human MAPKKK with two splice forms: MRK-alpha and MRK-beta.
  • MRK-beta preferentially activates ERK6/p38gamma and JNK signaling pathways.
  • MRK expression induces G(2)/M phase cell cycle arrest, and dominant-negative MRK attenuates gamma-radiation-induced G(2) arrest.
  • Gamma-radiation exposure increases MRK activity.

Conclusions:

  • MRK is a novel MAPKKK involved in gamma-radiation signaling.
  • MRK activity is essential for mediating cell cycle arrest in response to DNA damage.
  • MRK plays a critical role in cell cycle checkpoint regulation.

More Related Videos

Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...